✦ LIBER ✦

P58. Can T-cells predict response to intravesical BCG immunotherapy in high-risk non-invasive bladder cancer

✍ Scribed by Jallad, S; Thomas, P; Newport, M; Kern, F

Book ID: 125405079
Publisher: Springer (Biomed Central Ltd.)
Year: 2014
Tongue: English
Weight: 80 KB
Volume: 2
Category: Article
ISSN: 2051-1426
DOI: 10.1186/2051-1426-2-S2-P32

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urovysion™ testing can lead to ear

Urovysion™ testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer

✍ Whitson, Jared M.; Berry, Anna B.; Carroll, Peter R.; Konety, Badrinath R. 📂 Article 📅 2009 🏛 SciELO 🌐 English ⚖ 499 KB

1783 LONG-TERM OUTCOMES OF ELECTRO-MOTIV

1783 LONG-TERM OUTCOMES OF ELECTRO-MOTIVE DRUG ADMINISTRATION OF MITOMYCIN-C AFTER FAILED INTRAVESICAL BCG IMMUNOTHERAPY IN HIGH RISK, NON-MUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER

✍ Crawford, Ruairidh; Wright, Hannah; Borwell, Jonathan; Parker, Theresa; Montgome 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

Failure to achieve a complete response t

Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer

✍ Seth P. Lerner; Catherine M. Tangen; Heidi Sucharew; David Wood; E. David Crawfo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 316 KB

597 CANCER STEM CELLS (CSC) RESPONSES AN

597 CANCER STEM CELLS (CSC) RESPONSES AND TOLL-LIKE RECEPTORS (TLRS) AND P53 SIGNALING PATHWAY: EFFECTS OF BACILLUS CALMETTE-GUERIN (BCG) AND SUPERANTIGEN STAPHYLOCOCCAL ENTEROTOXIN B (SEB) IMMUNOTHERAPIES IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)

✍ Reis, Leonardo; Billis, Athanase; Fávaro, Wagner 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

433 EFFICACY AND SAFETY OF MYCOBACTERIAL

433 EFFICACY AND SAFETY OF MYCOBACTERIAL CELL WALL DNA COMPLEX IN THE TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER AT HIGH RISK OF PROGRESSION AND WHO ARE REFRACTORY TO BCG

✍ A. Morales; H.W. Herr; G.D. Steinberg; A.M. Kamat; R. Given; C. Lihou; Z. Cohen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 176 KB

IS EARLY SINGLE-DOSE INSTILLATION OF EPI

IS EARLY SINGLE-DOSE INSTILLATION OF EPIRUBICIN ABLE TO IMPROVE BCG EFFICACY IN NON-MUSCLE INVASIVE HIGH-RISK BLADDER CANCER PATIENTS? RESULTS FROM A PROSPECTIVE, RANDOMISED, DOUBLE-BLIND AND CONTROLLED STUDY

✍ R. Bartoletti; T. Cai; N. Mondaini; G. Nesi; S. Mazzoli; V. Boddi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB